ClinicalTrials.gg
Sign In
Status unknownNCT02624154Updated Dec 8, 2015

Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing Survival

An observational study in Pancreatic Neuroendocrine Tumor, sponsored by First Affiliated Hospital, Sun Yat-Sen University. Status unknown. Open to participants aged 10 Years to 80 Years. Per ClinicalTrials.gov, last updated 2015-12-08.

Sponsored by First Affiliated Hospital, Sun Yat-Sen University · Observational

The sponsor has not verified this record recently (last verified Nov 2015), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
2
Ages
10 Years to 80 Years
Sex
All
01

Study summary

Investigator determined the factor of surgery associated with the survival of pancreatic neuroendocrine tumor.

Read the detailed description

The variables including clinical characteristics, surgical data and pathological findings are examined by univariate and multivariate analyses.

02

Conditions studied

  • Pancreatic Neuroendocrine Tumor

Browse trials for

03

In context

Adenoma, Islet Cell

102 studies on the registry are indexed under Adenoma, Islet Cell; 27 are open to participants now.

This study's planned enrollment of 2 is below the median of 70 across 23 observational studies indexed under Adenoma, Islet Cell.

Browse Adenoma, Islet Cell studies →

Lead sponsor

First Affiliated Hospital, Sun Yat-Sen University is the lead sponsor of 161 studies on the registry; 54 are open to participants now.

Browse First Affiliated Hospital, Sun Yat-Sen University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Investigators selected the patient who underwent pancreatectomy during the time from 2010 to 2013 at the First Affiliated Hospital of Sun Yat-sen University.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The patients with pancreatic neuroendocrine tumor underwent pancreatectomy

Exclusion criteria

Exclusion Criteria:

  • The patients with pancreatic neuroendocrine tumor did not undergo pancreatectomy
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
2 participants (estimated)
Patient registry
No

Interventions

  • Procedurepancreatectomy

    Remove the pancreatic neuroendocrine tumor by surgery

06

What researchers measure

Primary outcomes

  1. The survival rate

    Time frame: 3 years

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2015, a primary completion of Jun 2016 and a completion of Dec 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 30, 2015
First posted
Dec 8, 2015
Start
Dec 2015
Primary completionEst.
Jun 2016
CompletionEst.
Dec 2016
Last update
Dec 8, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 8, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02624154
Lead sponsor
First Affiliated Hospital, Sun Yat-Sen University
Responsible party
Qinchang Chen (Principal Investigator, First Affiliated Hospital, Sun Yat-Sen University) — Principal investigator
First posted
Dec 8, 2015
Start date
Dec 2015
Primary completion
Jun 2016 (estimated)
Completion
Dec 2016 (estimated)
Last update
Dec 8, 2015

Study contacts

Qinchang Chen, Doctor
Contact
337809622@qq.com
18819430530
Shaowei Gao, Doctor
study director · First Affiliated Hospital, Sun Yat-Sen University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Adenoma, Islet Cell →

Other studies from this sponsor

First Affiliated Hospital, Sun Yat-Sen University →

Start the discussion